Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • Bitcoin USD

    64,230.92
    +1,104.68 (+1.75%)
     

  • CMC Crypto 200

    1,382.72
    +70.10 (+5.34%)
     

  • S&P 500

    4,957.31
    -53.81 (-1.07%)
     

  • Dow

    37,874.47
    +99.09 (+0.26%)
     

  • Nasdaq

    15,249.27
    -352.23 (-2.26%)
     

  • Gold

    2,410.90
    +12.90 (+0.54%)
     

  • Crude Oil

    83.13
    +0.40 (+0.48%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Merck aims to hike revenues in China to 1 bln eur by 2018

Reuters

FRANKFURT (Reuters) - Merck will start offering non-prescription drugs in China as part of a push to double revenues in the region to 1 billion euros ($1.3 billion) by 2018, Chief Executive Karl-Ludwig Kley told German weekly Wirtschaftswoche.

Merck will focus on treatments related to diabetes, thyroid issues and heart problems, and supply medication made at a new factory in Nantong which is due to start production in 2017, Wirtschaftswoche said.

($1 = 0.7447 Euros)

(Reporting by Edward Taylor; Editing by Ruth Pitchford)